HighLight Capital (investor - Venture Capital)
		See something wrong or missing? Let us know
	
Offices:Tokyo
		
		
		
		
			Average round investment:96.77M USD
			Average number per year:1.0
			
				
					Distribution:
					2025 (1)
					
				
			
			
				
					Portfolio companies:
					 Nuclidium
 Nuclidium
					
				
			
			
				 Nuclidium
 Nuclidium
					
				
					Mostly invests in:
					 Switzerland (1)
					Biotech (1)
 Switzerland (1)
					Biotech (1)
				
			
		
	 Switzerland (1)
					Biotech (1)
 Switzerland (1)
					Biotech (1)
				1 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.

 Belgium
 Belgium Netherlands
 Netherlands Austria
 Austria Germany
 Germany Denmark
 Denmark Estonia
 Estonia Finland
 Finland Iceland
 Iceland Latvia
 Latvia Lithuania
 Lithuania Norway
 Norway Sweden
 Sweden France
 France Ireland
 Ireland Italy
 Italy Portugal
 Portugal Spain
 Spain United Kingdom
 United Kingdom